Christopher C. Davis
Known title: DirectorCIK: 0001350384
Associated companies
Transaction History
| GHC | ▲ Buy | Grant | 23 | $27K | 7/1/2026 | View on chart |
| GHC | ▲ Buy | Grant | 25 | $27K | 4/1/2026 | View on chart |
| GHC | ▲ Buy | Grant | 25 | $27K | 1/2/2026 | View on chart |
| GHC | ▲ Buy | Grant | 23 | $27K | 10/1/2025 | View on chart |
| GHC | ▲ Buy | Grant | 28 | $27K | 7/1/2025 | View on chart |
| GHC | ▲ Buy | Grant | 28 | $27K | 4/1/2025 | View on chart |
| GHC | ▲ Buy | Grant | 31 | $27K | 1/2/2025 | View on chart |
| GHC | ▲ Buy | Grant | 34 | $27K | 10/1/2024 | View on chart |
| GHC | ▲ Buy | Grant | 39 | $27K | 7/1/2024 | View on chart |
| GHC | ▲ Buy | Grant | 36 | $27K | 4/1/2024 | View on chart |
| GHC | ▲ Buy | Grant | 39 | $27K | 1/2/2024 | View on chart |
| GHC | ▲ Buy | Grant | 47 | $27K | 10/2/2023 | View on chart |
| GHC | ▲ Buy | Grant | 48 | $27K | 7/3/2023 | View on chart |
| GHC | ▲ Buy | Grant | 46 | $27K | 4/3/2023 | View on chart |
| GHC | ▲ Buy | Grant | 45 | $27K | 1/3/2023 | View on chart |
| GHC | ▲ Buy | Grant | 50 | $27K | 10/3/2022 | View on chart |
| GHC | ▲ Buy | Grant | 47 | $27K | 7/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Kaplan ranks No. 1 workplace; enrollment concerns persist
Kaplan, a key Graham Holdings unit, was named the No. 1 Best Workplace in Education and Training for 2026. However, a recent survey indicates admissions officers are worried about a potential enrollment cliff despite a competitive application cycle. The company faces mixed signals from its education segment while maintaining a low valuation.
Kaplan ranks No. 1 workplace; enrollment concerns persist. Kaplan, a key Graham Holdings unit, was named the No. 1 Best Workplace in Education and Training for 2026. However, a recent survey indicates admissions officers are worried about a potential enrollment cliff despite a competitive application cycle. The company faces mixed signals from its education segment while maintaining a low valuation.